Vogt A B, Kropshofer H, Kalbacher H, Kalbus M, Rammensee H G, Coligan J E, Martin R
Center of Medical and Natural Sciences, University of Tübingen, Germany.
J Immunol. 1994 Aug 15;153(4):1665-73.
Antigenic peptides are presented to CD4+ T cells by MHC class II molecules via a highly polymorphic peptide-binding groove. The two HLA-DR alleles isotypically expressed on HLA-DR15Dw2-positive cells, DRB11501 (DR2b) and DRB50101 (DR2a) molecules, show a number of differences in polymorphic residues of the beta-chain, including the Gly-Val-dimorphism at position beta 86. Therefore, different requirements for interaction of peptides with these alleles must be expected. In this study, naturally processed self-peptides were eluted from purified HLA-DR15Dw2 molecules and related to DRB11501 or DRB50101 molecules by binding assays. An alignment of self-peptides and foreign peptides allowed the delineation of putative anchor motifs. N- and C-terminally truncated and alanine-substituted derivatives of the DR15Dw2 restricted myelin basic protein epitope MBP(85-105) confirmed their validity. Thus, DRB50101 requires a bulky hydrophobic residue (F or Y) at position i as a primary anchor, and Q or an aliphatic residue, such as V, I, or M, at position i + 3; positively charged residues at positions i + 7 and i + 8 are secondary anchors. For DRB11501, a nonaromatic, hydrophobic anchor (L, V, or I) at position i is supplemented by a bulky hydrophobic residue (F or Y) at position i + 3 as primary anchor; an additional hydrophobic side chain represented by M, I, V, or F occurs at position i + 6. Therefore, MBP(85-105) seems to contain two MHC interaction sites for DRB11501 and DRB50101, respectively, that may contribute to its immunodominance. Because HLA-DR15 Dw2 is associated with susceptibility to develop multiple sclerosis, the delineation of ligand motifs of the two DR2 alleles may help to study the interaction between potential autoantigenic peptides and these molecules in the future.
抗原肽通过高度多态性的肽结合槽由MHC II类分子呈递给CD4 + T细胞。在HLA - DR15Dw2阳性细胞上同型表达的两个HLA - DR等位基因,即DRB11501(DR2b)和DRB50101(DR2a)分子,在β链的多态性残基上存在许多差异,包括β86位的甘氨酸 - 缬氨酸二态性。因此,可以预期肽与这些等位基因相互作用的不同要求。在本研究中,从纯化的HLA - DR15Dw2分子中洗脱天然加工的自身肽,并通过结合试验将其与DRB11501或DRB50101分子相关联。自身肽和外来肽的比对允许描绘推定的锚定基序。DR15Dw2限制的髓鞘碱性蛋白表位MBP(85 - 105)的N端和C端截短以及丙氨酸取代衍生物证实了它们的有效性。因此,DRB50101需要在i位有一个大的疏水残基(F或Y)作为主要锚定,在i + 3位有Q或一个脂肪族残基,如V、I或M;在i + 7和i + 8位带正电荷的残基是次要锚定。对于DRB11501,在i位的一个非芳香族疏水锚定(L、V或I)由在i + 3位的一个大的疏水残基(F或Y)作为主要锚定补充;在i + 6位出现由M、I、V或F代表的另一个疏水侧链。因此,MBP(85 - 105)似乎分别包含两个与DRB11501和DRB50101的MHC相互作用位点,这可能有助于其免疫显性。因为HLA - DR15 Dw2与患多发性硬化症的易感性相关,两个DR2等位基因的配体基序的描绘可能有助于未来研究潜在自身抗原肽与这些分子之间的相互作用。